Nicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment
Press Release Nicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment …
Press Release Nicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment …
ALLSCHWIL, Switzerland, Dec. 11, 2020 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) today announced the…
DXS INTERNATIONAL PLC Notification of Director / PDMR Dealing The Board of DXS International plc…
The Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in…
Marseille, Dec. 11, 2020 (GLOBE NEWSWIRE) — Innate will no longer pursue Lumoxiti commercialization activities…
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to…
Innate will no longer pursue Lumoxiti commercialization activities in US or EU; Company to re-focus…
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage…
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
LAS VEGAS, Dec. 10, 2020 (GLOBE NEWSWIRE) — Shop1, a U.S. dropshipping platform bringing 80,000+…